Literature DB >> 6115575

Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.

R Canepa-Anson, J R Dawson, P Kuan, C A Warnes, P A Poole-Wilson, S R Reuben, G C Sutton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6115575     DOI： 10.1016/0002-8703(81)90747-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  5 in total

1.  Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction.

Authors:  A Peacock; C Busst; K Dawkins; D M Denison
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

Review 2.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

Review 3.  Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

4.  Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.

Authors:  R Canepa-Anson; J R Dawson; P Kuan; P A Poole-Wilson; G C Sutton; B Cockrill; S R Reuben
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

5.  Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.

Authors:  J Bayliss; M Norell; R Canepa-Anson; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1983-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.